This Article Full Text (PDF) All Versions of this Article: 0009922809332680v1 48/6/601    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Haddy, T. B. Articles by Reaman, G. H. PubMed PubMed Citation Articles by Haddy, T. B. Articles by Reaman, G. H. Social Bookmarking                         What's this?

Late Effects in Long-Term Survivors After Treatment for Childhood Acute Leukemia

Department of Pediatric Hematology-Oncology, Children's National Medical Center, Washington, DC, tbhaddy{at}aol.com

Revonda B. Mosher, MSN, CPNP

Department of Pediatric Hematology-Oncology, Sinai Hospital of Baltimore, Baltimore, Maryland

Gregory H. Reaman, MD

Department of Pediatric Hematology-Oncology, Children's National Medical Center, Washington, DC

Background. This is a report of late effects in childhood cancer survivors seen in the follow-up clinic of a single institution. Materials and methods. There were 324 acute leukemia survivors in the database of the Long Term Follow Up Clinic of Children's National Medical Center from January 1, 1997, through June 30, 2005. Results. Of the 324 acute leukemia survivors, 228 were white, 48 black, 20 Hispanic, and 12 other. Their follow-up time was 0 to 25 years (mean 5.3 years). One or more adverse events occurred in 74.1% of the 324 survivors. Defective physical growth was most commonly reported, followed by disturbed neurocognitive function, emotional difficulties, cardiac abnormalities, hypertension, osteoporosis/osteopenia, fractures, and second neoplasms. More black and Hispanic children had acute myeloid leukemia, relapses, cardiac problems, and hypertension than white and other subjects. Conclusion. Childhood cancer survivors require lifelong monitoring, with prompt identification and treatment of adverse late effects.

Key Words: acute leukemia • childhood cancer • follow-up • late effects • survivors

This version was published on July 1, 2009

Clinical Pediatrics, Vol. 48, No. 6, 601-608 (2009)
DOI: 10.1177/0009922809332680


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?